Cells,
Journal Year:
2020,
Volume and Issue:
9(10), P. 2297 - 2297
Published: Oct. 15, 2020
The
janus
kinase
(JAK)/signal
transducer
and
activator
of
transcription
(STAT)
signaling
pathway
is
associated
with
the
regulation
essential
cellular
mechanisms,
such
as
proliferation,
invasion,
survival,
inflammation,
immunity.
Aberrant
JAK/STAT
contributes
to
cancer
progression
metastatic
development.
STAT
proteins
play
an
role
in
development
cervical
cancer,
inhibition
may
be
for
enhancing
tumor
cell
death.
Persistent
activation
different
STATs
present
a
variety
cancers,
including
their
overactivation
poor
prognosis
overall
survival.
oncoproteins
E6
E7
critical
mediate
pathway.
Inhibition
appears
show
promise
establishing
new
targets
treatment.
review
summarizes
knowledge
about
participation
components
human
papillomavirus
(HPV)
process
malignancy.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: June 19, 2023
T
cells
are
crucial
for
immune
functions
to
maintain
health
and
prevent
disease.
cell
development
occurs
in
a
stepwise
process
the
thymus
mainly
generates
CD4
European Journal of Immunology,
Journal Year:
2021,
Volume and Issue:
51(12), P. 2708 - 3145
Published: Dec. 1, 2021
Abstract
The
third
edition
of
Flow
Cytometry
Guidelines
provides
the
key
aspects
to
consider
when
performing
flow
cytometry
experiments
and
includes
comprehensive
sections
describing
phenotypes
functional
assays
all
major
human
murine
immune
cell
subsets.
Notably,
contain
helpful
tables
highlighting
differences
between
cells.
Another
useful
feature
this
is
analysis
clinical
samples
with
examples
applications
in
context
autoimmune
diseases,
cancers
as
well
acute
chronic
infectious
diseases.
Furthermore,
there
are
detailing
tips,
tricks
pitfalls
avoid.
All
written
peer‐reviewed
by
leading
experts
immunologists,
making
an
essential
state‐of‐the‐art
handbook
for
basic
researchers.
Frontiers in Immunology,
Journal Year:
2021,
Volume and Issue:
12
Published: May 3, 2021
Current
success
of
immunotherapy
in
cancer
has
drawn
attention
to
the
subsets
T
H
cells
tumor
which
are
critical
for
activation
anti-tumor
response
either
directly
by
themselves
or
stimulating
cytotoxic
cell
activity.
However,
presence
immunosuppressive
pro-tumorigenic
milieu
further
contributes
complexity
regulation
cell-mediated
immune
response.
In
this
review,
we
present
an
overview
multifaceted
positive
and
negative
effects
cells,
with
emphasis
on
different
subtypes
various
how
a
delicate
balance
contradictory
signals
can
influence
overall
immunotherapy.
We
focus
regulatory
network
that
encompasses
dendritic
cell-induced
CD4
+
1
subsequent
priming
CD8
along
intersecting
anti-inflammatory
2
discuss
other
infiltrating
such
as
immunostimulatory
9
fh
reg
duality
17
function
contribute
tip
anti-
vs
responses
tumor.
highlight
developing
knowledge
against
neoantigens/oncodrivers,
impact
current
strategies
immunity,
opposing
action
be
explored
amplify
patients.
Understanding
nuances
molecular
framework
undergirding
balancing
act
between
is
rational
designing
immunotherapies
bypass
therapeutic
escape
maximize
potential
Brain,
Journal Year:
2021,
Volume and Issue:
144(7), P. 2047 - 2059
Published: March 8, 2021
α-Synuclein,
a
key
pathological
component
of
Parkinson's
disease,
has
been
implicated
in
the
activation
innate
and
adaptive
immune
system.
This
includes
microgliosis,
increased
inflammatory
cytokines,
infiltration
T
cells
into
CNS.
More
recently,
peripherally
circulating
CD4
CD8
derived
from
individuals
with
disease
have
shown
to
produce
Th1/Th2
cytokines
response
α-synuclein,
suggesting
there
may
be
chronic
memory
cell
present
disease.
To
understand
potential
effects
these
α-syn
associated
responses
we
used
an
α-synuclein
overexpression
mouse
model,
cell-deficient
mice,
combination
immunohistochemistry
flow
cytometry.
In
this
study,
found
that
midbrain
mice
leads
upregulation
major
histocompatibility
complex
II
(MHCII)
protein
on
CNS
myeloid
as
well
IFNγ
producing
Interestingly,
genetic
deletion
TCRβ
or
CD4,
use
immunosuppressive
drug
fingolimod,
were
able
reduce
MHCII
α-synuclein.
Furthermore,
observed
CD4-deficient
protected
dopaminergic
loss
due
overexpression.
These
results
suggest
pathology
damaging
areas
targeting
could
avenue
for
modifying
treatments.
Signal Transduction and Targeted Therapy,
Journal Year:
2022,
Volume and Issue:
7(1)
Published: Sept. 22, 2022
RNA
modifications
have
become
hot
topics
recently.
By
influencing
processes,
including
generation,
transportation,
function,
and
metabolization,
they
act
as
critical
regulators
of
cell
biology.
The
immune
abnormality
in
human
diseases
is
also
a
research
focus
progressing
rapidly
these
years.
Studies
demonstrated
that
participate
the
multiple
biological
processes
cells,
development,
differentiation,
activation,
migration,
polarization,
thereby
modulating
responses
are
involved
some
related
diseases.
In
this
review,
we
present
existing
knowledge
functions
underlying
mechanisms
modifications,
N6-methyladenosine
(m6A),
5-methylcytosine
(m5C),
N1-methyladenosine
(m1A),
N7-methylguanosine
(m7G),
N4-acetylcytosine
(ac4C),
pseudouridine
(Ψ),
uridylation,
adenosine-to-inosine
(A-to-I)
editing,
summarize
their
roles
Via
regulating
can
pathogenesis
diseases,
such
cancers,
infection,
inflammatory
autoimmune
We
further
highlight
challenges
future
directions
based
on
knowledge.
All
all,
review
will
provide
helpful
well
novel
ideas
for
researchers
area.
Cell Research,
Journal Year:
2020,
Volume and Issue:
30(4), P. 328 - 342
Published: March 20, 2020
Adaptive
immunity
is
essential
for
pathogen
and
tumor
eradication,
but
may
also
trigger
uncontrolled
or
pathological
inflammation.
T
cell
receptor,
co-stimulatory
cytokine
signals
coordinately
dictate
specific
signaling
networks
that
the
activation
functional
programming
of
cells.
In
addition,
cellular
metabolism
promotes
responses
dynamically
regulated
through
interplay
serine/threonine
kinases,
immunological
cues
nutrient
networks.
this
review,
we
summarize
upstream
regulators
effectors
key
kinase-mediated
networks,
including
PI3K-AGC
mTOR
LKB1-AMPK
pathways
regulate
metabolism,
especially
in
We
provide
our
perspectives
about
pending
questions
clinical
applicability
immunometabolic
signaling.
Understanding
uncover
therapeutic
targets
to
modulate
metabolic
human
disease.
Biomedicines,
Journal Year:
2021,
Volume and Issue:
9(7), P. 791 - 791
Published: July 8, 2021
The
spliced
form
of
X-box
binding
protein
1
(XBP1s)
is
an
active
transcription
factor
that
plays
a
vital
role
in
the
unfolded
response
(UPR).
Under
endoplasmic
reticulum
(ER)
stress,
unspliced
Xbp1
mRNA
cleaved
by
activated
stress
sensor
IRE1α
and
converted
to
mature
encoding
XBP1
(XBP1s).
Translated
XBP1s
migrates
nucleus
regulates
transcriptional
programs
UPR
target
genes
ER
molecular
chaperones,
folding
enzymes,
ER-associated
degradation
(ERAD)
components
decrease
stress.
Moreover,
studies
have
shown
diverse
are
involved
lipid
glucose
metabolism
immune
responses.
Therefore,
has
been
considered
important
therapeutic
studying
various
diseases,
including
cancer,
diabetes,
autoimmune
inflammatory
diseases.
several
unique
mechanisms
regulate
different
interacting
with
other
proteins
modulate
their
activity.
Although
recent
discovered
numerous
via
genome-wide
analyses,
how
remains
unclear.
This
review
discusses
roles
regulation.
More
in-depth
knowledge
regulatory
future
will
help
develop
new
targets
for
each
disease.
Immunological Reviews,
Journal Year:
2020,
Volume and Issue:
295(1), P. 15 - 38
Published: March 25, 2020
Abstract
The
evolutionarily
conserved
serine/threonine
kinase
mTOR
(mechanistic
target
of
rapamycin)
forms
the
distinct
protein
complexes
mTORC1
and
mTORC2
integrates
signals
from
environment
to
coordinate
downstream
signaling
events
various
cellular
processes.
T
cells
rely
on
activity
for
their
development
establish
homeostasis
functional
fitness.
Here,
we
review
recent
progress
in
our
understanding
upstream
targets
mTOR.
We
also
provide
an
updated
overview
roles
T‐cell
development,
homeostasis,
activation,
effector‐cell
fate
decisions,
as
well
its
important
impacts
suppressive
regulatory
cells.
Moreover,
summarize
emerging
exhaustion
transdifferentiation.
A
better
contribution
decisions
will
ultimately
aid
therapeutic
targeting
human
disease.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: April 18, 2024
Abstract
Cancer,
a
complex
and
multifactorial
disease,
presents
significant
challenge
to
global
health.
Despite
advances
in
surgical,
radiotherapeutic
immunological
approaches,
which
have
improved
cancer
treatment
outcomes,
drug
therapy
continues
serve
as
key
therapeutic
strategy.
However,
the
clinical
efficacy
of
is
often
constrained
by
resistance
severe
toxic
side
effects,
thus
there
remains
critical
need
develop
novel
therapeutics.
One
promising
strategy
that
has
received
widespread
attention
recent
years
repurposing:
identification
new
applications
for
existing,
clinically
approved
drugs.
Drug
repurposing
possesses
several
inherent
advantages
context
since
repurposed
drugs
are
typically
cost-effective,
proven
be
safe,
can
significantly
expedite
development
process
due
their
already
established
safety
profiles.
In
light
this,
present
review
offers
comprehensive
overview
various
methods
employed
repurposing,
specifically
focusing
on
treat
cancer.
We
describe
antitumor
properties
candidate
drugs,
discuss
detail
how
they
target
both
hallmarks
tumor
cells
surrounding
microenvironment.
addition,
we
examine
innovative
integrating
with
nanotechnology
enhance
topical
delivery.
also
emphasize
role
play
when
used
part
combination
regimen.
To
conclude,
outline
challenges
associated
consider
future
prospects
these
transitioning
into
application.
Reproduction,
Journal Year:
2022,
Volume and Issue:
164(2), P. R11 - R45
Published: May 13, 2022
The
syndrome
of
preterm
labor
comprises
multiple
established
and
novel
etiologies.
This
review
summarizes
the
distinct
immune
mechanisms
implicated
in
birth
highlights
potential
strategies
for
its
prevention.